AFRM shorts build as Goldman trims target ahead of November earnings
Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Affirm Holdings heads into its November 5 earnings report with short sellers adding exposure and the Street trimming targets, even as the bull case remains intact.
Short interest has been the clearest directional signal this week. Positions have climbed 8% over the past seven days to 6.1% of the free float, and the monthly build is steeper still, up 31.6% over 30 days. That brings shorts to their highest level in recent months on a share-count basis. The borrow market, however, offers no squeeze tension to counterbalance that accumulation. Availability is exceptionally loose at 2,730%, meaning there are roughly 27 shares still available to borrow for every one already lent out. The ORTEX short score has nudged up to 43.1 from 41.3 two weeks ago, reflecting the incremental build, but at the 34th percentile on short score rank it remains well below levels that would signal a crowded or extreme positioning. Cost to borrow is a negligible 0.44%, unchanged on the week. Put together, shorts are adding but conditions make that straightforward and cheap to do.
Options positioning is slightly less defensive than its recent norm. The put/call ratio is 1.15, just below its 20-day average of 1.19 and nearly a full standard deviation lighter on puts than that mean. The 52-week range runs from 0.81 to 1.25, so the current level sits comfortably in the middle. That places options traders in a mild risk-on stance relative to recent weeks, a small contrast to the short-side accumulation happening simultaneously.
The most market-moving development on the analyst front is Goldman Sachs cutting its price target on October 13, from $115 to $103, while keeping its Buy rating. TD Cowen made a similar move a week earlier, trimming from $124 to $110 but staying positive. Both cuts land the stock further above its current price of $74.01, and the consensus target across all rated analysts is $98.59, implying around 33% upside from current levels. The broader analyst posture is constructive: bulls cite Affirm's two-sided payments network, merchant-subsidised zero-interest products, and the potential of agentic checkout to lift conversion on higher-ticket items, with bank-originated loan volumes and ABS spread compression as additional margin tailwinds. Bears focus on credit cycle exposure, with more than 70% of transaction volume in interest-bearing loans making delinquency rates and funding costs the key pressure points. Customer concentration adds another layer of fragility: the top four merchants account for 40% of gross merchandise volume. On earnings quality, Affirm ranks in the 98th percentile on EPS surprise and the 86th on 90-day EPS momentum, both among the strongest reads in its factor profile. The EV/EBITDA multiple is running at 15.8x, down modestly over 30 days.
The insider register from SEC EDGAR is worth noting, though it reduces to a narrower story on closer inspection. CFO Robert O'Hare exercised options and sold shares on October 9, netting a sale of 65,591 shares at $80.02 for roughly $5.2 million, all under a pre-arranged 10b5-1 plan. Plan-driven sales carry limited informational weight as a sentiment read since they are scheduled in advance, often well before the trade date. The Chief Accounting Officer, Siphelele Jiyane, made two open-market sales in September totalling roughly $3.8 million, and those were not under a 10b5-1 plan. Net insider disposition over 90 days is about $16.7 million. No offsetting open-market purchases appear in the recent filing record.
On the institutional side, JP Morgan Asset Management added nearly 9.9 million shares in its most recently reported period, a notable increase in absolute terms. Capital Research and Management held 14.6% of shares as of September 30, adding modestly. Morgan Stanley trimmed its 13G stake from 8.1% to 7.1% in a May filing. No 13D activist positions appear on the register, and the disclosure caveat applies throughout: these are positions as last disclosed around the 5% threshold, and holders that drop below that level are not obligated to file again.
With Affirm reporting on November 5, the conversation over the next three weeks centres on whether the sequential build in short interest reflects genuine scepticism about credit quality heading into the print, or is simply tactical positioning ahead of a known catalyst, at borrowing costs that make the trade essentially free.
Stocks in this article
See the live data behind this article on ORTEX.
Open AFRM on ORTEX →How this article was generated
- Generated
- 18 Oct 2026, 17:37
- Data as of
- 18 Oct 2026, 17:37
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.